Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Authorised
- Spectinomycin sulfate
- Lincomycin hydrochloride
Product identification
Medicine name:
Linco-Spectin 100 222 mg/g - 444.7 mg/g Powder for use in drinking water
Linco-Spectin 100 222 mg/g - 444.7 mg/g Poeder voor oraal gebruik
Linco-Spectin 100 222 mg/g - 444.7 mg/g Poudre orale
Linco-Spectin 100 222 mg/g - 444.7 mg/g Pulver zum Einnehmen
Active substance:
- Spectinomycin sulfate
- Lincomycin hydrochloride
Target species:
-
Pig
-
Chicken
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Spectinomycin sulfate575.90milligram(s)1.00gram(s)
-
Lincomycin hydrochloride241.90milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for use in drinking water
Withdrawal period by route of administration:
-
Oral use
-
Pig
-
Meat and offalno withdrawal period0 days; Animals must not be slaughtered for human consumption during treatment.
-
-
Chicken
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Linco-Spectin 100 222 mg/g - 444.7 mg/g pwdr. for drinking water 1.5 kg
- Linco-Spectin 100 222 mg/g - 444.7 mg/g pwdr. for drinking water 150 g
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium SA
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V061957
Date of authorisation status change:
Reference member state:
-
Belgium
Procedure number:
- BE/V/0029/001
Concerned member states:
-
Austria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?: